litlas
ログインアカウント作成

George Grunberger

1982–2024 年に発表

68
論文数
20,104
被引用数
61
h 指数
67
i10 指数

被引用数

George Grunberger の年別被引用数1984 年: 被引用 1 件1985 年: 被引用 9 件1986 年: 被引用 14 件1987 年: 被引用 15 件1988 年: 被引用 12 件1989 年: 被引用 15 件1990 年: 被引用 9 件1991 年: 被引用 6 件1992 年: 被引用 1 件1993 年: 被引用 2 件1994 年: 被引用 5 件1995 年: 被引用 3 件1996 年: 被引用 4 件1997 年: 被引用 2 件1998 年: 被引用 2 件1999 年: 被引用 1 件2000 年: 被引用 5 件2001 年: 被引用 7 件2002 年: 被引用 20 件2003 年: 被引用 38 件2004 年: 被引用 37 件2005 年: 被引用 33 件2006 年: 被引用 42 件2007 年: 被引用 36 件2008 年: 被引用 33 件2009 年: 被引用 23 件2010 年: 被引用 42 件2011 年: 被引用 75 件2012 年: 被引用 72 件2013 年: 被引用 102 件2014 年: 被引用 101 件2015 年: 被引用 123 件2016 年: 被引用 139 件2017 年: 被引用 167 件2018 年: 被引用 201 件2019 年: 被引用 711 件2020 年: 被引用 829 件2021 年: 被引用 713 件2022 年: 被引用 604 件2023 年: 被引用 465 件2024 年: 被引用 752 件2025 年: 被引用 315 件2026 年: 被引用 26 件

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,128 件、この内訳の 26.5%イギリス: 引用元論文 591 件、この内訳の 7.3%中国: 引用元論文 496 件、この内訳の 6.2%イタリア: 引用元論文 386 件、この内訳の 4.8%ドイツ: 引用元論文 354 件、この内訳の 4.4%オーストラリア: 引用元論文 291 件、この内訳の 3.6%カナダ: 引用元論文 279 件、この内訳の 3.5%スペイン: 引用元論文 262 件、この内訳の 3.3%デンマーク: 引用元論文 222 件、この内訳の 2.8%インド: 引用元論文 177 件、この内訳の 2.2%フランス: 引用元論文 172 件、この内訳の 2.1%日本: 引用元論文 155 件、この内訳の 1.9%
0%26.5%その他 31.4%

機関

分野

  • Medicine84.5%
  • Biochemistry, Genetics and Molecular Biology9.3%
  • Health Professions1.7%
  • Neuroscience1.1%
  • Nursing0.7%
  • Computer Science0.5%
  • その他2.2%

トピック

  • Diabetes Management and Research14.8%
  • Diabetes Treatment and Management10.8%
  • Pancreatic function and diabetes7.4%
  • Diabetes and associated disorders6.1%
  • Hyperglycemia and glycemic control in critically ill and hospitalized patients5.2%
  • Diabetes, Cardiovascular Risks, and Lipoproteins4.5%
  • その他51.2%

共著者

全論文

検索で開く
  1. Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range

    著者: Tadej Battelino, Thomas Danne, Richard M. Bergenstal, Stephanie A. Amiel, Roy W. Beck, Torben Biester, Emanuele Bosi, Bruce A. Buckingham, William T. Cefalu, Kelly L. Close, Claudio Cobelli, Eyal Dassau, J. Hans DeVries, Kim C. Donaghue, Klemen Dovč, Francis J. Doyle, Satish K. Garg, George Grunberger, Simon Heller, Lutz Heinemann, Irl B. Hirsch, Roman Hovorka, Weiping Jia, Olga Kordonouri, Boris Kovatchev, Aaron J. Kowalski, Lori M. Laffel, Brian J. Levine, Alexander Yur'evich Mayorov, Chantal Mathieu, Helen R. Murphy, Revital Nimri, Kirsten Nørgaard, Christopher G. Parkin, Éric Renard, David Rodbard, Banshi Saboo, Desmond Schatz, Keaton Stoner, Tatsuiko Urakami, Stuart A. Weinzimer, Moshe Phillip - Diabetes Care 2019 被引用: 3,797

  2. Glucose Management Indicator (GMI): A New Term for Estimating A1C From Continuous Glucose Monitoring

    著者: Richard M. Bergenstal, Roy W. Beck, Kelly L. Close, George Grunberger, David B. Sacks, Aaron J. Kowalski, Adam S. Brown, Lutz Heinemann, Grazia Aleppo, Donna B. Ryan, Tonya D. Riddlesworth, William T. Cefalu - Diabetes Care 2018 被引用: 662

  3. American Association of Clinical Endocrinologists and American College of Endocrinology Guidelines for Management of Dyslipidemia and Prevention of Cardiovascular Disease

    著者: Paul S. Jellinger, Yehuda Handelsman, Paul D. Rosenblit, Zachary T. Bloomgarden, Vivian Fonseca, Alan J. Garber, George Grunberger, Chris Guerin, David S.H. Bell, Jeffrey I. Mechanick, Rachel Pessah‐Pollack, Kathleen Wyne, Donald A. Smith, Eliot A. Brinton, Sergio Fazio, Michael H. Davidson, Paul S. Jellinger, Yehuda Handelsman, David S.H. Bell, Zachary T. Bloomgarden, Eliot A. Brinton, Michael H. Davidson, Sergio Fazio, Vivian Fonseca, Alan J. Garber, George Grunberger, Chris Guerin, Jeffrey I. Mechanick, Rachel Pessah‐Pollack, Paul D. Rosenblit, Donald A. Smith, Kathleen Wyne, Michael A. Bush, Farhad Zangeneh, Yehuda Handelsman, David S.H. Bell, Zachary T. Bloomgarden, Eliot A. Brinton, Sergio Fazio, Vivian Fonseca, Alan J. Garber, George Grunberger, Chris Guerin, Paul S. Jellinger, Paul D. Rosenblit, Donald A. Smith, Kathleen Wyne, Michael H. Davidson - Endocrine Practice 2017 被引用: 1,098

  4. American Association of Clinical Endocrinology Clinical Practice Guideline: The Use of Advanced Technology in the Management of Persons With Diabetes Mellitus

    著者: George Grunberger, Jennifer L. Sherr, Myriam Bermudez Allende, Thomas Blevins, Bruce W. Bode, Yehuda Handelsman, Richard Hellman, Rosemarie Lajara, V. Roberts, David Rodbard, Carla Stec, Jeff Unger - Endocrine Practice 2021 被引用: 277

  5. Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Management of Dyslipidemia and Prevention of Cardiovascular Disease Algorithm – 2020 Executive Summary

    著者: Yehuda Handelsman, Paul S. Jellinger, Chris Guerin, Zachary T. Bloomgarden, Eliot A. Brinton, Matthew J. Budoff, Michael H. Davidson, Daniel Einhorn, Sergio Fazio, Vivian Fonseca, Alan J. Garber, George Grunberger, Ronald M. Krauss, Jeffrey I. Mechanick, Paul D. Rosenblit, Donald A. Smith, Kathleen Wyne - Endocrine Practice 2020 被引用: 248

  6. Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Comprehensive Type 2 Diabetes Management Algorithm – 2020 Executive Summary

    著者: Alan J. Garber, Yehuda Handelsman, George Grunberger, Daniel Einhorn, Martin J. Abrahamson, Joshua I. Barzilay, Lawrence Blonde, Michael A. Bush, Ralph A. DeFronzo, Jeffrey R. Garber, W. Timothy Garvey, Irl B. Hirsch, Paul S. Jellinger, Janet B. McGill, Jeffrey I. Mechanick, Leigh Perreault, Paul D. Rosenblit, Susan L. Samson, Guillermo E. Umpierrez - Endocrine Practice 2020 被引用: 603

  7. International Consensus on Risk Management of Diabetic Ketoacidosis in Patients With Type 1 Diabetes Treated With Sodium–Glucose Cotransporter (SGLT) Inhibitors

    著者: Thomas Danne, Satish K. Garg, Anne L. Peters, John B. Buse, Chantal Mathieu, Jeremy Pettus, Charles M. Alexander, Tadej Battelino, Francisco Javier Ampudia‐Blasco, Bruce W. Bode, Bertrand Cariou, Kelly L. Close, Paresh Dandona, Sanjoy Dutta, Ele Ferrannini, Spiros Fourlanos, George Grunberger, Simon Heller, Robert R. Henry, Martin J. Kurian, Jake A. Kushner, Tal Oron, Christopher G. Parkin, Thomas R. Pieber, Helena W. Rodbard, Desmond Schatz, Jay S. Skyler, William V. Tamborlane, Koutaro Yokote, Moshe Phillip - Diabetes Care 2019 被引用: 356

  8. American Association of Clinical Endocrinologists and American College of Endocrinology Position Statement on the Association of SGLT-2 Inhibitors and Diabetic Ketoacidosis

    著者: Yehuda Handelsman, Robert R. Henry, Zachary T. Bloomgarden, Sam Dagogo‐Jack, Ralph A. DeFronzo, Daniel Einhorn, Ele Ferrannini, Vivian Fonseca, Alan J. Garber, George Grunberger, Derek LeRoith, Guillermo E. Umpierrez, Matthew R. Weir - Endocrine Practice 2016 被引用: 357

  9. Glycemic Outcomes in Adults With T1D Are Impacted More by Continuous Glucose Monitoring Than by Insulin Delivery Method: 3 Years of Follow-Up From the COMISAIR Study

    著者: Jan Šoupal, Lenka Petruželková, George Grunberger, Aneta Hašková, Milan Flekač, Martin Matoulek, O. MIKEŠ, Tomáš Pelcl, J Škrha, Eva Horová, J Škrha, Christopher G. Parkin, Š Svačina, Martin Prázný - Diabetes Care 2019 被引用: 241

  10. Improved Glycemia with Hybrid Closed-Loop Versus Continuous Subcutaneous Insulin Infusion Therapy: Results from a Randomized Controlled Trial

    著者: Satish K. Garg, George Grunberger, Ruth S. Weinstock, Margaret L. Lawson, Irl B. Hirsch, Linda A. DiMeglio, Rodica Pop‐Busui, Athena Philis‐Tsimikas, Mark Kipnes, David R. Liljenquist, Ronald Brazg, Yogish C. Kudva, Bruce A. Buckingham, Janet B. McGill, Anders L. Carlson, Amy Criego, Mark P. Christiansen, Kevin B. Kaiserman, Kurt Griffin, Gregory P. Forlenza, Bruce W. Bode, Robert H. Slover, Ashleigh Keiter, Chenxiao Ling, Briggitte Marinos, Toni L. Cordero, John Shin, Scott W. Lee, Andrew S. Rhinehart, Robert A. Vigersky, for the Adult and Pediatric MiniMed™ HCL Outcomes 6-month RCT: HCL versus CSII Control Study Group, Ashleigh Downs, Samantha Lange, Emily Jost, ANGELA J. KARAMI, Donna Hamill, Vinaya Simha, Donna Desjardins, Shelly McCrady Spitzer, Corey Reid, Ravinderjeet Kaur, Malone, Mary Halvorson, Laya Ekhlaspour, Christine Weir, Luis Casaubon, Lynn Ang, Kara Mizokami‐Stout, Cindy Plunkett, Brittany Williams, Carol Recklein, Mary Jane Clifton - Diabetes Technology & Therapeutics 2022 被引用: 60

  11. Early intervention and intensive management of patients with diabetes, cardiorenal, and metabolic diseases

    著者: Yehuda Handelsman, Javed Butler, George L. Bakris, Ralph A. DeFronzo, Gregg C. Fonarow, Jennifer B. Green, George Grunberger, James L. Januzzi, Samuel Klein, Pamela Kushner, Darren K. McGuire, Erin D. Michos, Javier Morales, Richard E. Pratley, Matthew R. Weir, Eugene E. Wright, Vivian Fonseca - Journal of Diabetes and its Complications 2023 被引用: 97

  12. Ertugliflozin in Patients with Stage 3 Chronic Kidney Disease and Type 2 Diabetes Mellitus: The VERTIS RENAL Randomized Study

    著者: George Grunberger, Sarah Camp, Jeremy Johnson, Susan Huyck, Steven G. Terra, James P. Mancuso, Zhi Wei Jiang, Gregory T. Golm, Samuel S. Engel, Brett Lauring - Diabetes Therapy 2017 被引用: 154

  13. DCRM 2.0: Multispecialty practice recommendations for the management of diabetes, cardiorenal, and metabolic diseases

    著者: Yehuda Handelsman, John E. Anderson, George L. Bakris, Christie M. Ballantyne, Deepak L. Bhatt, Zachary T. Bloomgarden, Biykem Bozkurt, Matthew J Budoff, Javed Butler, David Z.I. Cherney, Ralph A. DeFronzo, Stefano Del Prato, Robert H. Eckel, Gerasimos Filippatos, Gregg C. Fonarow, Vivian A. Fonseca, W. Timothy Garvey, Francesco Giorgino, Peter J Grant, Jennifer B. Green, Stephen J. Greene, Per-Henrik Groop, George Grunberger, Ania M. Jastreboff, Paul S. Jellinger, Kamlesh Khunti, Samuel Klein, Mikhail Kosiborod, Pamela Kushner, Lawrence A. Leiter, Norman E. Lepor, Christos S. Mantzoros, Chantal Mathieu, Christian W. Mende, Erin D. Michos, Javier Morales, Jorge Plutzky, Richard E. Pratley, Kausik K Ray, Peter Rossing, Naveed Sattar, Peter E.H. Schwarz, Eberhard Standl, Philippe Gabríel Steg, Lâle Tokgözoğlu, Jaakko Tuomilehto, Guillermo E Umpierrez, Paul Valensi, Matthew R. Weir, John Wilding, Eugene E. Wright - Metabolism 2024 被引用: 76

  14. DCRM Multispecialty Practice Recommendations for the management of diabetes, cardiorenal, and metabolic diseases

    著者: Yehuda Handelsman, John E. Anderson, George L. Bakris, Christie M. Ballantyne, Joshua A. Beckman, Deepak L. Bhatt, Zachary T. Bloomgarden, Biykem Bozkurt, Matthew J. Budoff, Javed Butler, Samuel Dagogo‐Jack, Ian H. de Boer, Ralph A. DeFronzo, Robert H. Eckel, Daniel Einhorn, Vivian Fonseca, Jennifer B. Green, George Grunberger, Chris Guerin, Silvio E. Inzucchi, Paul S. Jellinger, Mikhail Kosiborod, Pamela Kushner, Norman E. Lepor, Christian W. Mende, Erin D. Michos, Jorge Plutzky, Pam R. Taub, Guillermo E. Umpierrez, Muthiah Vaduganathan, Matthew R. Weir - Journal of Diabetes and its Complications 2021 被引用: 62

  15. Real-time CGM Is Superior to Flash Glucose Monitoring for Glucose Control in Type 1 Diabetes: The CORRIDA Randomized Controlled Trial

    著者: Aneta Hašková, Lucie Radovnická, Lenka Petruželková, Christopher G. Parkin, George Grunberger, Eva Horová, Vendula Navrátilová, Ondřej Kádě, Martin Matoulek, Martin Prázný, Jan Šoupal - Diabetes Care 2020 被引用: 146

  16. Benefits of LixiLan, a Titratable Fixed-Ratio Combination of Insulin Glargine Plus Lixisenatide, Versus Insulin Glargine and Lixisenatide Monocomponents in Type 2 Diabetes Inadequately Controlled on Oral Agents: The LixiLan-O Randomized Trial

    著者: Julio Rosenstock, Ronnie Aronson, George Grunberger, M Hanefeld, PierMarco Piatti, Pierre Sérusclat, Xi Cheng, Tianyue Zhou, Elisabeth Niemoeller, Elisabeth Souhami, Melanie J. Davies, on behalf of the LixiLan-O Trial Investigators - Diabetes Care 2016 被引用: 268

  17. Efficacy and safety of dulaglutide in the treatment of type 2 diabetes: a comprehensive review of the dulaglutide clinical data focusing on the AWARD phase 3 clinical trial program

    著者: Johan Jendle, George Grunberger, Thomas Blevins, Francesco Giorgino, Ryan T. Hietpas, Fady T. Botros - Diabetes/Metabolism Research and Reviews 2016 被引用: 154

  18. Role of chronic hyperglycemia in the pathogenesis of coronary microvascular dysfunction in diabetes

    著者: Marcelo F. Di Carli, James Janisse, Joel Ager, George Grunberger - Journal of the American College of Cardiology 2003 被引用: 489

  19. Consensus Statement By The American Association Of Clinical Endocrinologists And American College Of Endocrinology On The Comprehensive Type 2 Diabetes Management Algorithm – 2016 EXECUTIVE SUMMARY

    著者: Alan J. Garber, Martin J. Abrahamson, Joshua I. Barzilay, Lawrence Blonde, Zachary T. Bloomgarden, Michael A. Bush, Samuel Dagogo‐Jack, Ralph A. DeFronzo, Daniel Einhorn, Vivian Fonseca, Jeffrey R. Garber, W. Timothy Garvey, George Grunberger, Yehuda Handelsman, Robert R. Henry, Irl B. Hirsch, Paul S. Jellinger, Janet B. McGill, Jeffrey I. Mechanick, Paul D. Rosenblit, Guillermo E. Umpierrez - Endocrine Practice 2016 被引用: 875

  20. Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Comprehensive Type 2 Diabetes Management Algorithm – 2018 Executive Summary

    著者: Alan J. Garber, Martin J. Abrahamson, Joshua I. Barzilay, Lawrence Blonde, Zachary T. Bloomgarden, Michael A. Bush, Samuel Dagogo‐Jack, Ralph A. DeFronzo, Daniel Einhorn, Vivian Fonseca, Jeffrey R. Garber, W. Timothy Garvey, George Grunberger, Yehuda Handelsman, Irl B. Hirsch, Paul S. Jellinger, Janet B. McGill, Jeffrey I. Mechanick, Paul D. Rosenblit, Guillermo E. Umpierrez - Endocrine Practice 2018 被引用: 505

  21. Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Comprehensive Type 2 Diabetes Management Algorithm – 2019 Executive Summary

    著者: Alan J. Garber, Martin J. Abrahamson, Joshua I. Barzilay, Lawrence Blonde, Zachary T. Bloomgarden, Michael A. Bush, Samuel Dagogo‐Jack, Ralph A. DeFronzo, Daniel Einhorn, Vivian Fonseca, Jeffrey R. Garber, W. Timothy Garvey, George Grunberger, Yehuda Handelsman, Irl B. Hirsch, Paul S. Jellinger, Janet B. McGill, Jeffrey I. Mechanick, Paul D. Rosenblit, Guillermo E. Umpierrez - Endocrine Practice 2019 被引用: 298

  22. Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Comprehensive type 2 Diabetes Management Algorithm – 2017 Executive Summary

    著者: Alan J. Garber, Martin J. Abrahamson, Joshua I. Barzilay, Lawrence Blonde, Zachary T. Bloomgarden, Michael A. Bush, Samuel Dagogo‐Jack, Ralph A. DeFronzo, Daniel Einhorn, Vivian Fonseca, Jeffrey R. Garber, W. Timothy Garvey, George Grunberger, Yehuda Handelsman, Irl B. Hirsch, Paul S. Jellinger, Janet B. McGill, Jeffrey I. Mechanick, Paul D. Rosenblit, Guillermo E. Umpierrez - Endocrine Practice 2017 被引用: 435

  23. Improved Insulin Sensitivity and Resistance to Weight Gain in Mice Null for the Ahsg Gene

    著者: Suresh T. Mathews, Gurmant P. Singh, Mollie Ranalletta, Vivian J. Cintrón, Xiaoling Qiang, Anton Scott Goustin, Kai-Lin Catherine Jen, Maureen Charron, Willi Jahnen‐Dechent, George Grunberger - Diabetes 2002 被引用: 336

  24. Coverage for Continuous Glucose Monitoring for Individuals with Type 2 Diabetes Treated with Nonintensive Therapies: An Evidence-Based Approach to Policymaking

    著者: Grazia Aleppo, Irl B. Hirsch, Christopher G. Parkin, Janet B. McGill, Rodolfo J. Galindo, Davida Kruger, Carol J. Levy, Gregory P. Forlenza, Guillermo E. Umpierrez, George Grunberger, Richard M. Bergenstal - Diabetes Technology & Therapeutics 2023 被引用: 34